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To analyze the visual outcomes and rate of intraoperative complications of phacoemulsification surgery after prior 
pars plana vitrectomy. 
Design:  
Retrospective multicenter database study 
Participants: 
Eyes that underwent phacoemulsification between June 2005 and March 2015 at 8 sites in the United Kingdom  
Methods:  
Study eyes were classified either as vitrectomized (prior PPV group) or non-vitrectomized (reference group) 
depending on the vitreous state at the time of cataract surgery. Eyes with multiple intraocular surgeries or history of 
ocular diseases known to cause cataract progression or increased risk of intraoperative complications during 
phacoemulsification were excluded. 
Main Outcome Measures:  
Logarithm of the Minimum Angle of Resolution (logMAR) visual acuity (VA), rate of intraoperative complications, 
and time interval to cataract surgery.  
Results:  
Eyes in the prior PPV group (n =2,261) had worse preoperative logMAR VA (1.00 ±0.59 vs 0.63 ±0.54, p < 0.001), 
were from younger patients and had longer axial lengths than the non-vitrectomized group (n = 200,303). At all 
postoperative time points measured up to 24 weeks, mean vison was poorer in the prior PPV (0.38 ±0.47 vs 0.19 
±0.32 at 4-12 weeks, p < 0.001) and a smaller proportion of eyes achieved postoperative VA ≤ 0.30 logMAR 
(Snellen, ≥ 20/40) (64.4% vs 84.2% at 4-12 weeks, p < 0.001). The rate of posterior capsular rupture was not 
different between the prior PPV (1.7%) and the non-vitrectomized (1.7%) groups, but the incidence of zonular 
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dialysis (1.3% vs. 0.6%) and dropped nuclear fragments (0.8% vs. 0.2%) were higher in the prior PPV group (p < 
0.001). The mean time interval between PPV and cataract surgery was 399 days. Increased age and the use of longer 
duration intraocular tamponade were associated with a decreased time duration to cataract surgery, whereas the 
diagnosis of diabetes was associated with a longer time duration (p < 0.001).  
Conclusion:  
We found a significant improvement in VA with post-vitrectomy cataract surgery. However, compared to eyes 
without prior PPV, there was a worse mean postoperative vision of 0.2 logMAR units, a higher rate of zonular 




The surgical technique for pars plana vitrectomy (PPV) has evolved in the past decade, with expanded use for the 
treatment of various vitreoretinal disorders. Pars plana vitrectomy is commonly complicated by cataract formation or 
progression, occurring in a significant proportion of eyes, with up to 100% showing nuclear sclerotic cataract 
progression within 2 years postoperatively.1-4 Although the underlying pathophysiologic process of post-vitrectomy 
cataract formation remains unclear, a number of predisposing factors have been proposed, including traumatic 
crystalline lens injury at the time of PPV, phototoxicity, and lens protein oxidation.5-7  
Phacoemulsification cataract surgery in vitrectomized eyes may be associated with surgical challenges and an 
increased risk of operative complications.8-10 Lack of vitreous support can result in an abnormally deep and 
fluctuating anterior chamber during phacoemulsification, increased mobility of the posterior capsule, and zonular 
instability. Furthermore, direct zonular or crystalline lens damage may occur during PPV, thereby increasing the risk 
of complications in subsequent cataract surgery. Additionally, the use of intraocular tamponade agents at the time of 
PPV may cause stretching of the zonules, leading to zonular weakness.11, 12 While the effect of PPV on subsequent 
cataract surgery has been evaluated previously,10, 13-16 studies are scarce and generally limited by their sample size. 
The percentages of eyes achieving postoperative vision ≥ 20/40 also widely vary in previous studies, ranging from 
20% to 77%,13, 16, 21-24 making it difficult to draw firm conclusions on visual outcomes in vitrectomized eyes. 
Additionally, there are contradictory reports regarding the safety of phacoemulsification after prior PPV surgery. 
Cole and Charteris reported an overall intraoperative complication rate of 12.5%, and Ahfat et al. reported a 
posterior capsular rupture (PCR) rate of 13.3%;13, 14 in contrast, other studies have demonstrated a favorable safety 
profile, similar to that in non-vitrectomized eyes.15, 16  
With the above-mentioned shortcomings of the current literature in mind, we conducted a large multicenter cohort 
study using electronic medical record (EMR) data collected from eight United Kingdom (UK) National Health 
Service (NHS) ophthalmology sites to evaluate the visual outcomes and rate of intraoperative complications in post-
vitrectomy phacoemulsification cataract surgery. Additionally, we analyzed the time interval from PPV to cataract 
surgery and the factors influencing its duration including diabetic status, surgical complexity of prior PPV surgery, 
and the use of various intraocular tamponade agents.  
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Methods 
Data Extraction  
Anonymized cataract surgery data of 217,557 eyes collected between July 2003 and March 2015 at eight UK NHS 
hospitals using the same electronic medical record (EMR) system (Medisoft Ophthalmology, Medisoft Limited, 
Leeds, UK) were automatically extracted and pooled to a centralized database for analysis. All sites had large 
ophthalmology departments with a representative case mix of patients undergoing day-case cataract surgery, 
performed by a wide range of surgeons using modern phacoemulsification techniques. No particular surgeons were 
primarily involved in any of the study groups. Records included routinely captured patient level data, logged in 
standardized datasets developed by the UK Royal College of Ophthalmologists.17, 18 Data extracted included: age, 
gender, pre- and postoperative visual acuity (VA), PPV status and indications, type of intraocular tamponade, 
presence and type of operative complications, diabetic status, need for further ophthalmic surgery, and the time 
interval from PPV to cataract surgery. The EMR software was designed to ensure consistent and compulsory 
recording of intraoperative complications; prior to saving the operative note, physicians are prompted to select from 
a list of common complications associated with a given procedure or select that ‘no complication’ has occurred. As 
data was fully anonymized at the time of extraction, individual eyes, including those of patients undergoing bilateral 
sequential surgery during the study period, were included and treated as independent units for the purpose of 
analysis. This study was conducted in compliance with the Declaration of Helsinki, the National Institute for Health 
Research (NIHR), and the UK Data Protection Act. Anonymized database analyses of this type do not require 
ethical permission as they are viewed as clinical audit/service evaluation, in line with UK guidance.19  The Caldicott 
Guardian (who is responsible for overseeing data protection and ensuring confidentiality of patients’ information) at 
each center gave written approval for the automated anonymized data extraction. 
 
Data Categorization and Selection Criteria  
Of the 217,557 eyes on which phacoemulsification cataract surgery was performed, 8,475 had PPV prior to or 
combined with cataract surgery, and 209,082 eyes underwent only phacoemulsification without prior or 
simultaneous vitreoretinal surgery. Successive filtration steps were applied with exclusion of eyes that underwent 
phacoemulsification combined with additional intraocular surgeries (7,597 eyes), other than phacoemulsification 
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combined with silicone oil removal, and eyes where cataract surgery was performed using non-phacoemulsification 
surgical techniques (677 eyes). Eyes with a history of ocular diseases or treatments known to cause cataract 
formation or progression, independent of PPV surgery, including uveitis, endophthalmitis, and epimacular 
brachytherapy were also excluded, as were eyes with conditions known to increase the risk of complications during 
phacoemulsification, including blunt or penetrating trauma, and pseudoexfoliation syndrome (315 eyes). As well, we 
excluded eyes with missing operative dates or missing preoperative vision data (2,094 eyes). Eligible for analysis 
were a total of 202,564 eyes: 2,261 eyes with prior PPV (vitrectomized group) and 200,303 non vitrectomized eyes 
(reference group). Figure 1 details the distribution of eyes and the process of filtering used. 
 
For the purpose of analysis, we further classified the eyes in the prior PPV group based on the complexity and 
indication of PPV surgery into 4 groups: (1) complex vitrectomy (CV): PPV for complex retinal disease including 
advanced diabetic retinopathy necessitating delamination/segmentation and surgery for retinal detachment with 
proliferative vitreoretinopathy (PVR) more than grade B; (2) rhegmatogenous retinal detachment (RRD): including 
primary PPV ± scleral buckle for RRD with PVR grade B or less; (3) vitreoretinal interface (VRI) disorders: PPV 
for macular hole, epiretinal membrane, and vitreomacular traction; and (4) vitreous opacities (VO): PPV for vitreous 
floaters and vitreous hemorrhage (VH) due to any cause except those associated with diabetic retinopathy requiring 
membrane delamination and/or segmentation.  
 
Follow Up and Study Outcomes  
Standards of pre- and postoperative care for routine cataract surgery in UK NHS hospitals have been described in 
previous publications.20 The outcome variables for this study were VA, the incidence of intraoperative 
complications, and the time interval from PPV to phacoemulsification cataract surgery. Visual acuity was recorded 
using Snellen fractions or logarithm of minimal angle of resolution (logMAR) units and Snellen acuities were 
converted to logMAR for the purpose of analysis. Visual acuity was defined as the best value of uncorrected or 
corrected distance VA available at each time period. Preoperative VA was that recorded closest to the date of 
cataract surgery, no more than three months prior. Follow-up was recorded as occurring during three different time 
periods: 0-4 weeks, 4-12 weeks, and 12-24 weeks. Visual acuity at 4-12 weeks was selected as the primary 
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postoperative VA time period and included in the text; visual acuity at other postoperative time points are detailed in 
table 2. We defined vision gain after cataract surgery as improvement of ≥ 0.30 logMAR units (~3 Snellen lines). 
Statistical analysis  
Differences between mean pre- and postoperative VA were evaluated using paired, independent t-tests and chi 
square. To account for multiple testing in VA in-between groups, we used Bonferroni correction, resulting in a 
conservative p-value threshold for statistical significance of 0.003. We performed univariate and multivariate 
regression analyses to determine the impact of age, gender, type of intraocular tamponade, diabetic status, and 
indications for PPV surgery on the time duration from vitrectomy to cataract surgery; the p-value threshold used for 
statistical significance was 0.05. We used STATA version 13.0 to perform all the statistical analyses.  
Results 
Patient Demographics 
There were 2,261 eyes the prior PPV group and 200,303 eye in the reference, non vitrectomized group eligible for 
analysis. (Figure 1). Eyes in the prior PPV group belonged to patients who were younger (mean ± standard deviation 
[SD] 65.0 ± 9.8 years) than in the reference group (74.9 ± 10.5) (p < 0.001) and had longer axial lengths (24.3 ± 
1.6mm vs. 23.4 ± 1.0 mm, respectively; p < 0.001). Within the prior PPV group, patients’ mean age was lower (59.0 
± 10.8 years) in the CV subgroup in comparison to the RRD (62.3 ± 9.6), VRI (69.6 ± 7.1), and VO subgroups (64.7 
± 11.3) (p < 0.001). The mean axial length was higher in the RRD subgroup (25.1± 1.6 mm) than the VRI (23.6 ± 
1.2), VO (23.9 ± 1.3), and CV subgroups (23.2 ± 1.1) (p < 0.001). Baseline characteristics of both groups are shown 
in Table 1. 
Visual Outcome  
Baseline vision 
Preoperatively, there was a statstically significant difference in the mean VA between the prior PPV (1.00 ± 0.59 
logMAR) and reference groups (0.63 ± 0.54 logMAR), with better vision noted in the reference group (p < 0.001). A 
smaller proportion of eyes in the prior PPV group (12%) had baseline vision of ≤ 0.30 logMAR (Snellen, ≥ 20/40) 
as compared to reference group (35%) (p < 0.001). Within the prior PPV group, the CV subgroup had worse 
baseline logMAR VA (mean ± SD: 1.26 ± 0.74) than the RRD (0.94 ± 0.59), VO (1.00 ± 0.66), and VRI (0.94 ± 
0.52) subgroups (p < 0.001).  
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Postoperative Vision  
Table 2 details the mean postoperative VA at all postoperative time points. Vision improvement was achieved in 
both the prior PPV and reference groups, postoperatively (p < 0.001). However, we observed a worse mean 
postoperative VA in the prior PPV group as compared to the reference group; at 4-12 weeks, mean VA was 0.38 ± 
0.47 (~20/50 Snellen equivalent) in the prior PPV group and 0.19± 0.32 (~20/30 Snellen equivalent) in the reference 
group (p < 0.001).  
To further assess improvement of vision after cataract surgery, we analyzed the proportions of eyes with visual gains 
of ≥ 0.30 logMAR units (~3 Snellen lines) and those achieving a postoperative VA of ≤ 0.30 logMAR (Snellen, ≥ 
20/40). At 4-12 weeks, 858 eyes (81.2%) in the PPV group and 59,409 eyes (60.4%) in the reference group gained ≥ 
0.30 logMAR units (~3 Snellen lines) (p < 0.001). However, a smaller proportion of eyes achieved a postoperative 
VA of ≤ 0.30 logMAR (Snellen, ≥ 20/40) in the prior PPV group (681 eyes, 64.4%) as compared to the reference 
group (81,433, 84.2%) (p < 0.001). Within the prior PPV group, fewer eyes in the CV subgroup (28.8%) achieved 
postoperative VA ≤ 0.30 logMAR as compared to the RRD (70.2%), VRI (56.14%), and VO (59.5%) subgroups. As 
well, fewer eyes in CV subgroup (53.0%) gained ≥ 0.30 logMAR units (~3 Snellen lines) as compared to the RRD 
(77.2%), VRI (71.8%), and VO (71.4%) subgroups, however, these differences did not reach statistical significance.  
Intraoperative complications   
Table 3 shows the intraoperative complication rate in the prior PPV and reference groups. We did not find a 
significant difference in the overall rate of intraoperative complications between the prior PPV (4.3%) and reference 
groups (3.6%). Similarly, the rate of PCR did not differ between groups (1.7 % in both the prior PPV and reference 
groups). However, we found the rate of zonular dialysis and dropped nuclear/epinuclear fragments to be higher in 
the prior PPV group (1.3% and 0.8%, respectively) than in the reference group (0.6% and 0.2%, respectively; p < 
0.001). Within the prior PPV group, there was a trend toward a higher rate of PCR and zonular dialysis (4.1% and 
2.4%, respectively) in the CV subgroup as compared to the RRD (1.6% and 1.5%), VRI (1.0% and 1.0%) and VO 
(3.0% and 1.3%) subgroups, however, these differences did not reach statistical significance.  
 
Interval between pars plana vitrectomy surgery and phacoemulsification  
We found the mean (± SD) time duration from PPV to phacoemulsification cataract surgery to be 399 (± 415) days 
 10 
(range: 13 – 4365 days). Age and axial length were found to have a negative association with (shortened) the time 
interval to cataract surgery (Table 4). On the contrary, diabetic status was positively associated with (prolonged) the 
time interval to cataract surgery, with type I diabetes mellitus exhibiting a stronger positive association than type II. 
The influence of age, axial length and diabetic status was present in both univariate and multivariate analyses.  
Within the prior PPV group, we found significant differences between the prior PPV subgroups in the time duration 
from PPV to cataract surgery (p < 0.001); the longest (mean ± SD) duration was observed in the CV subgroup (1242 
± 924 days), followed by the VO (446 ± 456 days), VRI (376 ± 280 days), and RRD (313 days ± 266) subgroups. 
Regarding the effect of tamponade use on the time duration to cataract surgery, we found the use of intraocular 
tamponade during prior PPV surgery to be associated with a significantly shorter time interval from PPV to cataract 
surgery (mean ± SD; 362.5± 362 days) as compared to when no tamponade was used (528.9± 545 days) (p < 0.001). 
In eyes where intraocular tamponade was employed, air was associated with the longest duration to cataract surgery 
(mean ± SD; 581 ± 669), followed by SF6 (374 ± 349), C2F6 (351 ± 317), C3F8 (350 ± 338), and silicone oil (163 ± 
154). We found significant differences in duration between air and C2F6, C3F8, and silicone oil. However, while 
SF6 was found to be significantly different from air in univariate analysis (p < 0.001), this difference was not 





Discussion    
In this multicenter clinical database study, we examined the visual outcomes and the incidence of intraoperative 
complications in post-vitrectomy phacoemulsification cataract surgery. We found that nearly two-thirds of 
vitrectomized eyes achieved a postoperative ≤0.3 logMAR VA (Snellen, ≥20/40) after cataract surgery. Compared 
to eyes without prior PPV, there was a worse mean postoperative vision of approximately 2 Snellen lines, a higher 
rate of zonular dialysis and dropped nuclear fragments, and a similar rate of posterior capsule rupture. 
 
Significant variation exists in rate of the visual improvement reported in post-vitrectomy cataract surgery. Prior 
studies found that percentages of eyes achieving postoperative VA ≥ 20/40 range from 20% to 77%.13, 16, 21-24 This 
wide range may reflect variation in patient selection and baseline VA and differences in the severity of pre-existing 
vitreoretinal pathology. In this report, we found that vitrectomized eyes had worse baseline VA (1.00 vs 0.63 
logMAR, respectively) and showed a worse mean postoperative vision (0.38 vs 0.19, respectively) and a smaller 
potential for reaching a postoperative ≤0.3 logMAR VA (Snellen, ≥20/40) as compared to non-vitrectomized eyes 
(64.4% vs. 84.2 %, respectively) after cataract surgery. It is of note that the prior PPV group demonstrated better 
potential for gaining ≥ 0.30 logMAR units (~3 Snellen lines) from baseline as compared to the non-vitrectomized 
group (81.2% vs. 60.5%, respectively), which can be explained by a possible ceiling effect limiting the potential for 
improvement in the non-vitrectomized group with better baseline VA. Our data also suggests that visual gains after 
post-vitrectomy cataract surgery are largely dependent on the severity of vitreoretinal pathology and baseline vision. 
The CV subgroup had the poorest baseline vision and only approximately one-third of the eyes in this cohort 
achieved ≤0.3 logMAR VA (Snellen, ≥20/40) postoperative VA as compared to more than two-thirds of eyes in 
other prior PPV subgroups. Further, eyes in the CV subgroup showed significantly lower potential for significant 
visual gain (≥ 0.30 logMAR units) as compared to other prior PPV subgroups, despite a worse baseline VA before 
cataract surgery. Taken together, these findings demonstrate the impact of pre-existing retinal pathology on visual 
outcomes in post-vitrectomy cataract surgery.  
    
Previous studies on vitrectomized eyes though limited by their size, have shown variable rates of intraoperative 
complications with rates of PCR ranging from 0 - 13.3%, and zonular dialysis ranging from 0 - 6.7%. Table 5 details 
the rate of intraoperative complications in vitrectomized eyes observed in previous studies.10, 13-16, 25, 26 In our study, 
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the rate of PCR was not significantly different between the prior PPV and reference groups. However, zonular 
dialysis and dropped lens fragments were more frequent in the prior PPV group. Improved fluidics of 
phacoemulsification surgery has considerably facilitated the maintenance of anterior chamber stability. This may 
have helped to reduce the mobility of the posterior capsule in vitrectomized eyes undergoing cataract surgery, 
thereby decreasing the risk of PCR. On the other hand, trauma to the zonules during prior PPV surgery or as a result 
intraocular tamponade use is often unavoidable, and may account for the increased incidence of zonular dialysis in 
vitrectomized eyes and the higher rate of dropped nuclear fragments during subsequent cataract surgery.  
The effect of age on post-vitrectomy cataract formation has been evaluated in previous studies. Melberg and 
associates found a lower incidence of cataract formation after PPV in younger patients; over 25 months, nuclear 
sclerosis developed in only 7% of patients younger than 50 as compared to 79% older than 50. 27 This finding was 
also replicated in another study which showed subtle progression of cataract after PPV in patients younger than 50.28 
In keeping with the findings of these studies, we found patient’s age to significantly impact the time duration to 
cataract surgery, with younger age being assoicated with a longer time interval to post-vitrectomy cataract surgery.  
Although cataract formation is two to four fold more common in eyes with diabetes, 29, 30 following PPV, these eyes 
may require cataract extraction after a longer duration than in non-diabetics. It has been proposed that diabetes may 
exert a protective effect against the development of post-vitrectomy cataract formation owing to substantially lower 
oxygen tension in the vitreous humor of diabetic eyes as compared to non-diabetic eyes. Such a reduction is 
presumed to protect against oxidative damage to the lens and thereby delay the progression of cataract formation. 31 
Smidy, et al. reported a lower rate of cataract extraction after vitrectomy in eyes with diabetic retinopathy (15%) as 
compared to those with macular hole (53%) and ERM (66%) within 2 years of follow-up.32 In another study, 
cataract extraction was required in only 39% of diabetic eyes after 4 years of follow up.33 Ostri, et al. reported the 
longest follow-up after PPV; in their study, cataract extraction was performed in about 30%, 67% and 71% within 2, 
5 and 10 years, respectively.34 In our study, we found diabetic status to be associated with an increased time interval 
from PPV to cataract surgery, with a longer duration in type I diabetics as compared to type II. While it is possible 
that the younger age of type I diabetics may play a role in this difference, the effect of diabetes was found to be 
independent of the effect of age in our multivariate analysis model.  
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In keeping with prior studies that associated the use of intraocular tamponade during PPV and its duration with the 
risk of subsequent cataract development,35 we found the time interval between PPV and cataract surgery to be 
shorter with the use of intraocular tamponade as compared to when no tamponade was used. We also found this time 
interval to be negatively associated with the duration of the tamponade, with the exception of SF6 gas that was not 
significantly different from air. While silicone oil was associated with the shortest duration to cataract surgery, the 
majority (81%) of cataract surgeries in eyes with silicone oil were performed at the time of silicone oil removal. It is 
therefore possible that decision for removal of silicone oil may have influenced the timing of cataract surgery. 
Regarding the effect of PPV indication on the time of subsequent cataract surgery, we found the duration to be 
shortest in eyes where PPV was performed for RRD, followed by VRI disorders, then VO, and longest in the CV 
subgroup. In RRD surgery, more attention is paid to the removal of peripheral vitreous which may increase the risk 
of crystalline lens injury and accelerate the development of cataract. This is different from surgery for VO or VRI 
disorders where a more conservative vitrectomy approach is usually employed and surgery time is shorter. For the 
CV subgroup, it is of note that this cohort of eyes belonged to younger patients and included the highest proportion 
of diabetic eyes as compared to the other prior PPV subgroups (Table 1); these factors may at least in part explain 
the long duration to cataract surgery in this cohort despite increased surgical complexity. 
Our study has limitations. First, it is limited by the by its non-controlled, retrospective design and therefore it may 
be argued that unaccounted differences in preoperative ocular co-morbidities between the study groups may have 
influenced the visual outcomes. Additionally, similar to other database studies, not all patients in our study had 
follow up data for all postoperative time points. However, the scale of this study meant that at any single time point, 
more than 600 prior PPV eyes and 76,000 non-vitrectomized eyes were analyzed; at the primary postoperative time 
point at 4-12 weeks, 1,057 prior PPV eyes were analyzed – an unparalleled resource from a single study. 
Furthermore, we defined the distance VA as the best value of uncorrected or corrected distance VA available at each 
time point. It is therefore possible that including uncorrected VA values may have resulted in suboptimal final vision 
particularly in the post PPV eyes that may be more myopic and thus more likely to need postoperative refraction 
compared to the reference, non-vitrectomized group. However, because the standard of care for cataract surgery in 
the UK NHS includes a postoperative visit, 4 – 6 weeks post-surgery, in which eye refraction is routinely performed, 
we believe that the greatest proportion of distance VA values recorded at the primary postoperative VA time period 
(4-12 weeks) in this study are corrected values. Finally, we used the time interval from PPV to cataract surgery to 
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study different factors that could influence cataract progression after PPV such as patient’s age, diabetic status and 
PPV surgery indication. However, time interval to cataract surgery may be also influenced by the varying degrees of 
crystalline lens opacification prior to PPV and the differences in threshold for performing cataract surgery between 
surgeons and these factors were not possible to analyze in this study.  
As the indications for PPV are expanding and as cataract is by far the most common postoperative complication of 
PPV,36 our results may well influence clinical practice – the presented data will allow more accurate planning and  
counselling of patients regarding the visual outcome and the risk of intraoperative complications for cataract surgery 
in this setting. An added strength of the study is because recording of intraoperative complications in the EMR is a 
compulsory field, under-reporting bias of surgery complications is expected to be minimal. Our study provides a 
large resource of a non-selective cohort of post vitrectomy eyes from multiple centers where all data were gathered 
into prospectively fixed data fields, then analyzed retrospectively. As such, our findings are more informative than 
small studies and avoid the potential selection bias inherent to studies originating from single institutions. 
 
In summary, we found that approximately two-thirds of eyes undergoing post-vitrectomy phacoemulsification 
cataract surgery experienced increased vision; however, mean postoperative vision was approximately 2 lines worse 
than non-vitrectomized eyes and those with more complex vitreoretinal pathology were less likely to achieve VA ≥ 
20/40 after cataract surgery. We also found that the time interval to cataract surgery after PPV was shorter with prior 
use of longer acting intraocular tamponade agents and more prolonged in type 1 diabetics and younger patients. 
While the rate of PCR in vitrectomized eyes was comparable to non-vitrectomized eyes undergoing cataract surgery, 
there was a higher rate of zonular dialysis and dropped nuclear fragments in vitrectomized eyes. 
 
Table Legends: 
Table 1. Baseline demographics of the prior pars plana vitrectomy group and the reference (non-vitrectomized) 
group  
Table 2. Logarithm of the minimum angle of resolution (logMAR) vision of the prior pars plana vitrectomy group 
and the reference (non-vitrectomized) group at different time points. 
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Table 3. List of intraoperative complications in the prior pars plana vitrectomy group and the reference (non-
vitrectomized) group  
Table 4. Univariate and multivariate analysis of factors affecting the interval to cataract surgery in eyes with 
previous pars plana vitrectomy. 
Table 5. Rate of intraoperative complication of phacoemulsification in vitrectomized eyes in previous studies. 
 
Figure Legends: 
Figure 1. Flowchart illustrating the filtering process used to obtain the prior pars plana vitrectomy group and the 
reference (non-vitrectomized) group.  
Figure 2. Bar graph (mean ± 95% confidence interval) illustrating visual acuity, expressed in logarithm of the 
minimum angle of resolution (logMAR), at baseline and different postoperative time points (in weeks) after 
phacoemulsification surgery in the prior pars plana vitrectomy group and the reference (non-vitrectomized) group  
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